News and Comments

THREE SMALL BIOTECH FIRMS IN THE SPOTLIGHT

  Wednesday, July 31, 2013

Three biotechnology firms with market caps below $1billion have been recently put in the spotlight; SYNTA (SNTA) with a market cap of 535.54 million, ARRAY (ARRY) with a market cap of 774.22 million, and VANDA (VNDA) with a market cap of 320.45 million. More...


Recent Postings


Archive


Tags

OSI (OSIP) Gilead (GILD) SERES THERAPEUTICS (MCRB) Amgen (AMGN) Abbott Laboratories (ABT) Inovio (INO) KERYX (KERX) Alnylam (ALNY) Galena (GALE) Jazz Pharmaceuticals (JAZZ) TOKAI (TKAOI) Sanofi (SNA) VANDA (VNDA) Agenus (AGEN Regeneron (REGN) Anadys (ANDS) Roche (ROCHE) Multiple Myeloma Dynavax (DVAX) Herceptin SUNESIS PHARMACEUTICALS (SNSS) Ziofpharm (ZIOP) Elan (ELN) ZALTRAP™ NANTKWEST (NK) ADVENTRIX (ANX) Benlysta (belimumab) KITE (KITE) ImmunoGen (IMGN) Sequenom (SQNM) Rapamune Telaprevir Vertex (VRTX) Endometrial Cancer BIOMARIN (BMRN) Roche (RHHBY) Illumina (ILMN) Array Pharmaceuticals (ARRY) Ariad (ARIA) Theravance (THRX) Exelixis (EXEL) Ridaforolimus Pluristem (PSTI) Agenus (AGEN) Trastuzumab-DM1 JUNO (JUNO) Intrexon (XON) Valeant Pharmaceuticals International (VRX) GUARDIAN HEALTH HALOZYME (HALO) Sanofi-Aventis (SAN) Cytokinetics (CYTK) GlaxoSmithKline (GSK) Aimmune Therapeutics (AIMT) Sangamo (SGMO) Micromet (MITI) Merck (MRK) Incyte (INCY) Zerenex IDERA (IDRA) NEKTAR (NKTR)) Sarepta (SRPT) Bristol-Myers Squibb (BMY) Velcade (bortezomib) Seattle Genetics (SGEN) SYNTA (SNTA) Sanofi (SNY) Prolor Biotech (PBTH) CompuGen (CGEN) Idenix (IDIX) ARCA (ABIO) Intermune (ITMN) Auspex (ASPX) Biocryst (BCRX) Revlimid (lenolidamide) Tysabri ISIS (ISIS) Biogen Idec (BIIB) AERIE PHARMACEUTICALS Human Genome Sciences (HGSI) Onyx (ONXX) Genentech galapagos (GLPG) C4 Therapeutics Intercept (ICPT) Mirati Therapeutics (MRTX) ABBVIE (ABBV) Anacor (ANAC) Dendreon (DNDN) Prosensa (RNA) Xoma (XOMA)